Efficacy of Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in ER-positive Breast Cancer: Results From a Prospective Institutional Database-Reference-Cited by-同舟云学术

Efficacy of Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in ER-positive Breast Cancer: Results From a Prospective Institutional Database

Published:2019-12 Issue:6 Volume:19 Page:e683-e689
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

LeVasseur Nathalie,Willemsma Kaylie-Anne,Li Huaqi,Gondara Lovedeep,Yip Walter C.,Illmann Caroline,Chia Stephen K.,Simmons Christine

Funder

AbbVie

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference41 articles.

1. Primary chemotherapy for early and advanced breast cancer;Hortobagyi;Cancer Lett,1995

2. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18;Fisher;J Clin Oncol,1997

3. The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27

4. Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27;Mamounas;J Clin Oncol,2012

5. Preoperative chemotherapy for women with operable breast cancer;Mieog;Cochrane Database Syst Rev,2007

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant endocrine treatment in hormone receptor-positive breast cancer: Does it result in more breast-conserving surgery?;Breast Cancer Research and Treatment;2024-01-24

2. Advances in pharmacotherapies that target the cell cycle for treatment of breast cancer: where are we at today?;Expert Opinion on Pharmacotherapy;2023-04-12

3. Study protocol: Randomized, open-label, non-inferiority clinical trial for evaluating the clinical and pathological response rates to neoadjuvant hormone therapy and chemotherapy in patients with luminal-subtype breast tumors;Contemporary Clinical Trials Communications;2022-12

4. A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer;Clinical Breast Cancer;2022-01

5. Disease recurrence and oncological outcome of patients treated surgically with curative intent for estrogen receptor positive, lymph node negative breast cancer;Surgical Oncology;2021-06